Literature DB >> 8370283

A computer program for non-parametric receiver operating characteristic analysis.

S Vida1.   

Abstract

Sensitivity and specificity are key measures of the performance of a given test in detecting a given disorder. For tests yielding numerical scores, sensitivity and specificity usually vary inversely over the range of theoretically possible cutoff scores, complicating the task of quantifying and comparing the diagnostic accuracy of tests. Receiver Operating Characteristic analysis (ROC) approaches this problem by plotting the curve of sensitivity versus 1-specificity for all possible cutoff scores of the test. The area under the ROC curve (AUC) can be used to describe the diagnostic accuracy of the test. Parametric and non-parametric methods exist that allow the calculation of the AUC and the comparison of tests. A disadvantage of parametric formulations is the assumption of a normal or Gaussian distribution of test scores. The present article presents a computer program that utilizes non-parametric formulations that do not require the normal distribution of test scores. The program calculates the sensitivity and specificity of a test at all possible cutoff scores, plots the ROC curve, calculates the AUC, its standard error and 95% confidence limits, and allows the comparison of tests on independent and correlated samples.

Mesh:

Year:  1993        PMID: 8370283     DOI: 10.1016/0169-2607(93)90004-5

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  7 in total

1.  Diagnostic accuracy of serum biochemical fibrosis markers in children with chronic hepatitis B evaluated by receiver operating characteristics analysis.

Authors:  Dariusz Marek Lebensztejn; Elzbieta Skiba; Jolanta Tobolczyk; Maria Elzbieta Sobaniec-Lotowska; Maciej Kaczmarski
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  Receiver-operating characteristic analysis of multifocal VEPs to diagnose and quantify glaucomatous functional damage.

Authors:  Makoto Nakamura; Kumiko Ishikawa; Takayuki Nagai; Akira Negi
Journal:  Doc Ophthalmol       Date:  2011-08-19       Impact factor: 2.379

3.  Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis.

Authors:  K M Walsh; P Timms; S Campbell; R N MacSween; A J Morris
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

4.  Brief screens for detecting alcohol use disorder among 18-20 year old young adults in emergency departments: Comparing AUDIT-C, CRAFFT, RAPS4-QF, FAST, RUFT-Cut, and DSM-IV 2-Item Scale.

Authors:  Thomas M Kelly; John E Donovan; Tammy Chung; Oscar G Bukstein; Jack R Cornelius
Journal:  Addict Behav       Date:  2009-04-02       Impact factor: 3.913

5.  Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigen.

Authors:  J Russ Forney; Chansuda Wongsrichanalai; Alan J Magill; Leslie G Craig; Jeeraphat Sirichaisinthop; Christian T Bautista; R Scott Miller; Christian F Ockenhouse; Kent E Kester; Naomi E Aronson; Ellen M Andersen; Higinio A Quino-Ascurra; Carlos Vidal; Kimberly A Moran; Clinton K Murray; Caroline Cady DeWitt; D Gray Heppner; Kevin C Kain; W Ripley Ballou; Robert A Gasser
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

6.  Assessing the statistical significance of the achieved classification error of classifiers constructed using serum peptide profiles, and a prescription for random sampling repeated studies for massive high-throughput genomic and proteomic studies.

Authors:  James Lyons-Weiler; Richard Pelikan; Herbert J Zeh; David C Whitcomb; David E Malehorn; William L Bigbee; Milos Hauskrecht
Journal:  Cancer Inform       Date:  2005

7.  Serum EGF-receptor and HER-2 extracellular domains and prognosis of non-small-cell lung cancer.

Authors:  W Jacot; J-L Pujol; J-M Boher; P-J Lamy
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.